Press Release – New York, NY – December 4, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented A.G.P/Alliance Global Partners as financial advisor in the $8 million private …
Sichenzia Ross Ference Carmel LLP 代表 A.G.P/Alliance Global Partners 对 TransCode Therapeutics 进行 800 万美元私募
新闻稿 – 纽约州纽约 – 2024 年 12 月 4 日 – Sichenzia Ross Ference Carmel LLP 今天宣布，其在 TransCode Therapeutics, Inc.（纳斯达克股票代码：RNAZ）进行的 800 万美元私募发行中代表 A.G.P/Alliance Global Partners 作为财务顾问。 Sichenzia Ross Ference …
Sichenzia Ross Ference Carmel LLP represents Calidi Biotherapeutics, Inc. in $7.5 Million Public Offering
Press Release – New York, NY – November 14, 2024 – Sichenzia Ross Ference Carmel LLP announced that it represented Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (the “Company”), a clinical-stage …
Sichenzia Ross Ference Carmel LLP represents BullFrog AI Holdings, Inc. in $3.13 Million Registered Direct Offering and Concurrent Private Placement
Press Release – New York, NY – October 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a technology-enabled drug …
Sichenzia Ross Ference Carmel LLP represents Calidi Biotherapeutics, Inc. in a $2.05 Million Registered Direct Offering and Concurrent Private Placement
Press Release – New York, NY – October 23, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI), a clinical-stage …
Sichenzia Ross Ference Carmel LLP represents Lexaria Bioscience Corp. in $5 Million Registered Direct Offering and Concurrent Private Placement
Press Release – New York, NY – October 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery …
